Sprinter Doping Case Expands
A Florida man was indicted for providing banned substances in a case involving U.S. sprinter Marvin Bracy-Williams, who previously received a 45-month doping ban. The case underscores ongoing battles against performance-enhancing drugs in elite athletics and ramifications for American track and field.
- The Florida man indicted is Paul Askew of Jacksonville, who faces charges for violating the Rodchenkov Act, a 2020 law that allows for the prosecution of international doping conspiracies. If convicted, he could be sentenced to up to 10 years in prison. - Marvin Bracy-Williams' 45-month ban stems from two separate violations: a 21-month sanction for testosterone use and attempted tampering with the investigation, and an additional 24-month penalty for three "whereabouts failures" within a 12-month period. - The investigation into Bracy-Williams was initiated after the U.S. Anti-Doping Agency (USADA) received a tip from a whistleblower in early 2024. - After initially trying to hinder the investigation, Bracy-Williams later provided "substantial assistance" to authorities, which helped uncover other cases and led to a reduction in his own suspension. - The indictment against Askew alleges that from July 2023 to January 2024, he conspired to provide performance-enhancing drugs to an athlete to influence several major competitions, including the 2024 Paris Olympics and the 2023 Prefontaine Classic. - This case involves a multi-agency effort, with cooperation between USADA, the U.S. Drug Enforcement Administration (DEA), and the Athletics Integrity Unit (AIU), which handles doping cases for World Athletics. - Bracy-Williams, a 2016 Olympian, is disqualified from all competitive results on and after June 1, 2023, and his ban is effective through November 2028.
